Latest filing published 19 Oct 2026 for Iambic Therapeutics, Inc..
Insider track record
Michael Secora: trading record in brief
Michael Secora, listed as finance chief, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Recursion Pharmaceuticals, Inc. and Iambic Therapeutics, Inc. The record holds 32 filings, for trades running from 4 February 2022 to 16 October 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 19 October 2026, reports a transaction in Iambic Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael Secora
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 61,342 sharesCommon StockSEC:0001855980-26-000009:0
- 28,400 shares0Common StockSEC:0001855980-26-000007:0
- 11,937 shares@ US$6.1754.1% of flowClass A Common StockSEC:0001601830-24-000214:0
- 39,375 shares@ US$2.224.8% of flowClass A Common StockSEC:0001601830-24-000204:0
- 39,375 shares@ US$2.224.7% of flowClass A Common StockSEC:0001601830-24-000176:0
- 39,375 shares@ US$2.224.7% of flowClass A Common StockSEC:0001601830-24-000156:0
- 11,962 shares@ US$6.694.3% of flowClass A Common StockSEC:0001601830-24-000125:0
- 39,375 shares@ US$2.224.7% of flowClass A Common StockSEC:0001601830-24-000123:0
- 39,375 shares@ US$2.224.8% of flowClass A Common StockSEC:0001601830-24-000101:0
- 39,375 shares@ US$2.224.8% of flowClass A Common StockSEC:0001601830-24-000083:0
- 11,962 shares@ US$10.016.5% of flowClass A Common StockSEC:0001601830-24-000056:0
- 37,500 shares@ US$2.224.6% of flowClass A Common StockSEC:0001601830-24-000036:0
- 37,500 shares@ US$2.224.5% of flowClass A Common StockSEC:0001601830-24-000023:0
- 7,172 shares@ US$12.434.9% of flowClass A Common StockSEC:0001209191-24-003489:0
- 37,500 shares@ US$2.224.6% of flowClass A Common StockSEC:0001209191-24-003410:0
- 8,659 shares0Class A Common StockSEC:0001209191-24-003238:0
- 37,500 shares@ US$2.224.5% of flowClass A Common StockSEC:0001209191-24-001868:0
- 37,500 shares@ US$2.224.6% of flowClass A Common StockSEC:0001209191-23-058703:0
- 37,500 shares@ US$2.224.6% of flowClass A Common StockSEC:0001209191-23-055610:0
- 37,500 shares@ US$2.224.6% of flowClass A Common StockSEC:0001209191-23-052716:0
- 37,500 shares@ US$2.224.6% of flowClass A Common StockSEC:0001209191-23-049478:0
- 4,727 shares@ US$9.192.4% of flowClass A Common StockSEC:0001209191-23-046423:0
- 37,500 shares@ US$2.224.4% of flowClass A Common StockSEC:0001209191-23-042798:0
- 37,500 shares@ US$2.224.6% of flowClass A Common StockSEC:0001209191-23-037582:0
- 4,760 shares@ US$5.601.4% of flowClass A Common StockSEC:0001209191-23-030372:0
25 of 32 declarations
